TGFB1 and COVID-19: Unlike the rapid immune response during the early infection stage, a gene set enrichment analysis showed that patients with long-term COVID-19 exhibited significantly reduced immune activity (Figure 4C), especially in IFNγ and TGFβ (Figure 4D), while other metabolic pathways were not significantly changed.